LANSING - A group hoping to amend the Michigan Constitution to allow embryonic stem cell research in the state provided itself a substantial buffer in filing 570,016 signatures toward a spot on the November ballot. That filing launched the voter campaigns for both sides, as opponents did not expect to be able to disqualify enough
ANN ARBOR - Biopharmaceutical company NanoBio Corp has appointed announced Daniel B. Dubin, M.D., to its board of directors. Dr. Dubin currently serves as Vice Chairman and a Director at Leerink Swann, a leading healthcare and biotechnology investment banking firm. "Dr. Dan�'s keen understanding of the life sciences investment banking field and his clinical experience
LANSING - Under federal objections, certificate of need rules that required a proton beam therapy facility in the state to operate under a cooperative of hospitals were struck down. But the idea of a cooperative came back in the initial approval of a facility for Beaumont Hospitals. The Certificate of Need office granted initial approval
ANN ARBOR - NanoBio Corp. has been named to the annual FierceBiotech Fierce 15 list, designating the University of Michigan spin off as one of the top biotechnology companies in the country. NanoBio has developed a rich pipeline of anti-infective lotions and vaccines to combat a diverse range of bacteria, viruses and fungi, from MRSA
DETROIT - Covisint and AT&T are taking their health information sharing portal nationwide with the help of Microsoft Corp.'s HealthVault. Covisint, a subsidiary of Compuware, and AT&T first announced a statewide health information sharing system for the state of Tennessee earlier this year. Now, they?ve added Microsoft HealthVault, a platform for storing and accessing personal
BOSTON - The global biotechnology industry reached record levels in financing and deal making in 2007, with more than $29.9 billion in financing raised within the industry, a new study from Ernst & Young reports. In the study, Beyond Borders: Global Biotechnology Report 2008, Ernst & Young examines three key trends that are transforming business
ANN ARBOR - QuatRx Pharmaceuticals on Monday announced detailed primary endpoint results from Phase 3 clinical trial of Ophena (ospemifene tablets) to treat postmenopausal women with symptoms of vulvovaginal atrophy, a common condition associated with menopause. The successful trial brings QuatRx once step closer to commercialization. The study, the company said, successfully met all four
ANN ARBOR - The University of Michigan's Life Sciences Institute is launching a $10 million fund to shepherd promising biomedical discoveries from the lab bench to the marketplace, what biomedical researchers and venture capitalists call the Valley of Death. Called the Innovation Partnership, it uses philanthropic gifts to bridge this critical funding gap. More than
ANN ARBOR - MichBio has negotiated a special arrangement with the organizers of BioPharm America making its life science member companies eligible for a $200 registration discount for the BioPharm America 2008 conference Sept. 9-10 in Atlanta. Please note that you must state in the comment field within the online registration form that you are
ANN ARBOR - Biopharmaceutical company NanoBio Corporation has appointed David Stout, former president of Pharmaceutical Operations for GlaxoSmithKline Pharmaceuticals, to its board of directors. �??We are pleased to welcome David to our Board of Directors and look forward to benefiting from his guidance and contributions,�?� said James Baker Jr., M.D., chairman of NanoBio Corporation. �??David�??s